N※N

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 12, 2009) - Pyng Medical Corporation (TSX VENTURE:PYT) ("Pyng Medical" or the "Company") today announced that the Company has appointed George G. Dorin as the CFO effective November 5, 2009. Mr. Dorin is a Chartered Accountant and holds a Masters Degree in Finance from the London School of Economics in England. He has been a Chief Financial Officer and Vice President Finance for several private and public companies over the last 15 years.

Mr. Dorin's career in finance spans over twenty-five years. Most recently, he has been providing corporate finance and financial management advisory services to various industrial companies through his own firm, CANUS Capital Corporation.

"George has had a significant amount of financial management experience with internationally focused companies," stated the CEO Robert (Bob) Di Silvio. "On behalf of the board and management of Pyng Medical, I would like to welcome him to his new role as CFO with Pyng Medical."

About Pyng Medical Corp.
Pyng is a leader in resuscitation innovation with simple-to-use and highly effective products including the [ FAST1® Intraosseous Infusion System ], the FASTx^TM Sternal Intraosseous Device, [ T-POD® Pelvic Stabilizer ], and [ MAT® Tourniquet ]. The Company is awaiting FDA approval of the [ CRIC™ Cricothyrotomy System ] which is currently under final development. The Company plans to submit an application for FDA approval of the FASTx^TM System, which is currently still under development.

For further company information please access our website:[ www.Pyng.com ]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.